May 30th 2025, 9:00pm
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
May 30th 2025, 7:00pm
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
May 30th 2025, 5:00pm
There are many instances where teddy bears can be the key to opening hearts and minds during cancer care.
May 30th 2025, 3:00pm
The phase 1/2 STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell non-Hodgkin’s lymphomas.
May 30th 2025, 1:00pm
Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse and human tumor models.
May 30th 2025, 12:00pm
Braftovi and Erbitux plus chemotherapy improved survival without progression over standard therapy in BRAF V600E-mutant mCRC in the first-line setting.
May 29th 2025, 9:00pm
Dr. Jared Weiss sat down for an interview to discuss a trial evaluating JNJ-1900, an immune-stimulating radiation sensitizer, in those with lung cancer.
May 29th 2025, 8:00pm
A patient and provider share updates on pelabresib plus Rituxan treatment, which met the MANIFEST-2 trial's primary end point for those with myelofibrosis.
May 29th 2025, 7:00pm
Christine Simonelli, B.S.N., RN, CCRC, OCN, is amazing, and goes out of her way to help patients and providers.
May 29th 2025, 5:00pm
I want my family to understand our shared cancer risks, but I sometimes struggle to face the painful reality of the disease myself.
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025
What I Learned About Previvorship and Representation in Social Media